Bolt Biotherapeutics Inc.

AI Score

XX

Unlock

0.42
-0.02 (-4.02%)
At close: Mar 25, 2025, 3:56 PM
0.44
4.69%
After-hours: Mar 25, 2025, 07:17 PM EDT

Bolt Biotherapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 7.69M 7.88M 5.73M 1.26M 231K 215K n/a
Cost of Revenue n/a 1.88M 4.89M 3.67M 40.36M 26M 302K
Gross Profit 7.69M 5.99M 838K -2.41M -40.13M -25.79M -302K
Operating Income -73.05M -76.2M -90.32M -92.79M -49.18M -30.97M -11.63M
Interest Income n/a 7M 2.22M 281K 199K 524K 193K
Pretax Income -63.12M -69.2M -88.1M -98.59M -60.73M -30.49M -11.59M
Net Income -63.12M -69.2M -85.88M -104.39M -72.27M -30M -11.59M
Selling & General & Admin 18.46M 22.53M 22.93M 18.39M 9.06M 5.18M 2.21M
Research & Development 57.47M 61.54M 73.12M 75.66M 40.36M 26M 9.42M
Other Expenses 4.81M n/a n/a -6.08M -11.74M -42K -153K
Operating Expenses 80.74M 84.07M 96.05M 94.05M 49.41M 31.18M 11.63M
Interest Expense n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 80.74M 84.07M 96.05M 94.05M 49.41M 31.18M 11.63M
Income Tax n/a n/a -2.22M 5.8M 11.55M -482K 40K
Shares Outstanding (Basic) 38.18M 37.81M 37.36M 37.4M 36.25M 35.1M 9.42M
Shares Outstanding (Diluted) 38.18M 37.81M 37.36M 37.4M 36.25M 35.1M 9.42M
EPS (Basic) -1.65 -1.83 -2.3 -2.79 -1.99 -0.85 -1.23
EPS (Diluted) -1.65 -1.83 -2.3 -2.79 -1.99 -0.85 -1.23
EBITDA -73.05M -74.34M -88.66M -91.59M -48.57M -30.63M -11.33M
Depreciation & Amortization n/a 1.85M 4.89M 3.67M 2.5M 1.33M 302K